Inhibitor Therapeutics Inc INTI:OTCQB

RT Quote | Exchange | USD
Last | 11:49 AM EDT
0.092quote price arrow up+0.0008 (+0.88%)
Volume
6,000
52 week range
0.06 - 0.35
Loading...
  • Open0.10
  • Day High0.10
  • Day Low0.092
  • Prev Close0.0912
  • 52 Week High0.35
  • 52 Week High Date06/18/21
  • 52 Week Low0.06
  • 52 Week Low Date06/04/21

Key Stats

  • Market Cap34.67M
  • Shares Out376.86M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.11
  • YTD % Change-38.56

KEY STATS

  • Open0.10
  • Day High0.10
  • Day Low0.092
  • Prev Close0.0912
  • 52 Week High0.35
  • 52 Week High Date06/18/21
  • 52 Week Low0.06
  • 52 Week Low Date06/04/21
  • Market Cap34.67M
  • Shares Out376.86M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.11
  • YTD % Change-38.56

RATIOS/PROFITABILITY

  • EPS (TTM)-0.00
  • P/E (TTM)-108.24
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-251,150.00
  • ROE (TTM)-8,850.31%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-7.46%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Inhibitor Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Inhibitor Therapeutics, Inc. is a pharmaceutical development company. The Company is focused on developing and commercializing therapeutics for patients with certain cancers and certain non-cancerous proliferation disorders. The Company is focused on development of its lead product, SUBA-Itraconazole, an oral formulation of anti-fungal drug, Itraconazole, for any prostate cancer, prostatic intraepithelial neoplasia and benign prostatic hyperplasia; lung cancer and atypical...
William Watson CPA
Independent Chairman of the Board
Nicholas Virca
President, Chief Executive Officer
Garrison Hasara CPA
Chief Financial Officer, Chief Compliance Officer, Treasurer, Secretary
Address
4830 W. Kennedy Blvd., Suite 600
Tampa, FL
33609
United States

Top Peers

SYMBOLLASTCHG%CHG
SPRO
Spero Therapeutics Inc
1.24+0.04+3.33%
PHAS
PhaseBio Pharmaceuticals Inc
0.7796+0.0122+1.59%
APVO
Aptevo Therapeutics Inc
4.79+0.09+1.91%
ISR
IsoRay Inc
0.2841-0.007-2.4047%
FREQ
Frequency Therapeutics Inc
1.17+0.04+3.54%
LABP
Landos Biopharma Inc
0.72+0.1074+17.53%